1. Search Case laws by Section / Act / Rule — now available beyond Income Tax. GST and Other Laws Available
2. New: “In Favour Of” filter added in Case Laws.
Try both these filters in Case Laws →
TaxTMI Login
🚀 New: Section-Wise Filter ✕
Just a moment...
1. Search Case laws by Section / Act / Rule — now available beyond Income Tax. GST and Other Laws Available
2. New: “In Favour Of” filter added in Case Laws.
Try both these filters in Case Laws →
Press 'Enter' to add multiple search terms. Rules for Better Search
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
of 
Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
All Case Laws
of Press 'Enter' after typing page number.
of Press 'Enter' after typing page number.
All Case Laws
Note
Bookmark
Share
Don't have an account? Register Here
of Press 'Enter' after typing page number.
<h1>Government Retains Discretion on Rare Disease Drug Tax Exemptions and Import Protocols Under Existing Regulatory Framework</h1> HC dismissed writ petition challenging tax exemptions and import procedures for rare disease drugs. Court held government retains discretion on tax ... Direction to respondent to completely exempt drugs for treatment of rare diseases from the levy of IGST, CGST, SGT and Custom Duty - direction to respondents to permit import the drugs for treatment of SMA directly without approaching the Centre of Excellence - HELD THAT:- Ultimately it is for the Government to take a policy decision whether to completely exempt drugs for treatment of rare diseases from the levy of IGST, CGST, SGT and Custom Duty. No writ of mandamus can be issued directing the respondent/Union of India to exempt the drugs from payment of any tax or custom duty - No writ of mandamus can be issued directing the respondents to permit import the drugs for treatment of SMA directly without approaching the Centre of Excellence. There may be number of reasons why the drugs are to be cleared by the Centre of Excellence. The writ petition stands dismissed. Issues:1. Exemption of drugs for rare diseases from taxes2. Import of drugs for SMA treatment without approaching Centre of ExcellenceAnalysis:1. The petition sought a writ of mandamus to exempt drugs for rare diseases from IGST, CGST, SGT, and Custom Duty. The Court held that it is the Government's prerogative to decide on such exemptions, and no mandamus can be issued to enforce the exemption. Therefore, the petitioners were not granted relief in this regard.2. The petition also requested a writ to allow the direct import of drugs for SMA treatment without involving the Centre of Excellence. The Court refused to grant this relief, stating that there could be valid reasons for the drugs to be cleared by the Centre of Excellence. Consequently, the petitioners were not entitled to the relief sought in this aspect as well.3. In conclusion, the Court dismissed the writ petition, stating that the petitioners were not entitled to the reliefs they sought. However, the Court allowed the petitioners to make a representation to the Union of India/Ministry of Health regarding their concerns. Any pending interlocutory applications were also disposed of as a part of this judgment.
TaxTMI 
TaxTMI 
